NEW YORK (Reuters Health) – A proximal balloon occlusion device provided better protection against cerebral emboli than a filter device during coronary artery stenting (CAS) in the first…
NEW YORK (Reuters Health) – Three cardiologists from China say intracoronary administration of a glycoprotein IIb/IIIa receptor inhibitor (GPI) “can be recommended as a preferred regimen” during primary…
NEW YORK (Reuters Health) – Discontinuation of aspirin within 5 days of combined coronary artery bypass graft (CABG) and valve surgery is associated with an increased risk of…
NEW YORK (Reuters Health) – Percutaneous placement of a sirolimus-eluting stent (SES) is a safe and effective way to address either bare-metal (BMS) or drug-eluting (DES) in-stent restenosis,…
NEW YORK (Reuters Health) – The rate of radial artery occlusion after transradial catheterization increases with the size of arterial sheath used for the procedure, according to data…
NEW YORK (Reuters Health) – There is no solid evidence that drug-eluting stents (compared to bare-metal stents) increase the risk for stent thrombosis, death or myocardial infarction in…
NEW YORK (Reuters Health) – A direct comparison of four agents as monotherapy in drug-naive patients with type 2 diabetes shows that exenatide once-weekly, metformin, and pioglitazone provide…
NEW YORK (Reuters Health) – Silent embolic cerebral infarctions occur in about 1 in 6 patients after undergoing coronary angiography, and the risk is related to the degree…
NEW YORK (Reuters Health) – For primary percutaneous coronary intervention for ST-segment elevation MI, access via the radial artery is associated with better outcomes than is the femoral…
NEW YORK (Reuters Health) – For patients with significant mitral valve regurgitation who are not considered candidates for surgery, catheter-based mitral leaflet repair with the MitraClip device (Abbott…